Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUXGZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,204
Award facts
- Contract value 100% obligated
- $11,204.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,204.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent (dupilumab) auto-injector pens on April 21, 2025, with completion scheduled for April 22, 2025. This contract represents a non-competitive delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems.
Dupixent is a specialty pharmaceutical indicated for multiple immune-mediated conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order supports the Defense Health Agency's medical supply requirements through AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare operations. The contract was awarded without set-aside designation, consistent with AmerisourceBergen's track record of securing competitively awarded contracts with the DLA.
Quick answers
Who was awarded contract SPE2DB25FUXGZ?
SPE2DB25FUXGZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FUXGZ worth?
The government has obligated $11,204 on SPE2DB25FUXGZ.
Is contract SPE2DB25FUXGZ an order under another contract?
Yes. SPE2DB25FUXGZ is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUXGZ competed?
The extent of competition for SPE2DB25FUXGZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award